Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 1 of 23
Utility of a Mobile Application for Young Women With Breast Cancer
NCT07009093
RIsE Stroke Mobility Study
NCT07638462
Enhancing Slow Wave Sleep in Depression
NCT07143838
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
NCT07046936
Comprehensive Care for AYA: Needs Assessment Survey
NCT07196241
Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
NCT07474090
Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy
NCT07324577
BOOST: Blended Onsite and Offsite Structured Exercise Training and Coaching
NCT07413198
Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology
NCT06897137
Telehealth and Remote Blood Pressure
NCT07356518
Physician Engagement in EMS Transport Refusal Rates
NCT07107737
Walk On! National Council on Aging Innovation Lab
NCT07368907
Culturally Tailored Program for Food-Insecure Adults: SPICE-D
NCT07361341
A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
NCT07322367
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
NCT07175376
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
NCT07291297
Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
NCT06876896
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
NCT03258658
Pre-malignant States to Hematologic Malignancies in Firefighters
NCT06870760
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
NCT07119489
Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer
NCT07278414
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
NCT07227051
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
NCT07203534
Vital Coach: A Study of Resiliency in Medical Students
NCT07342673
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
NCT07215624
Evaluation of Flexible Conductive Hearing Aids
NCT07222202
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
NCT06904287
Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
NCT06819254
R.E.C.K vs Exparel in Robotic Nephrectomy
NCT07092566
Deprescribing in Outpatient Internal Medicine Practices
NCT07226960
Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
NCT05871606
Comparison of Urinary Flow Study
NCT06918067
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
NCT07053774
Oral Gastric Suctioning Effect on Transesophageal Echo
NCT07209293
A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
NCT07033169
Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial
NCT06942754
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
NCT06904391
Bump the Lump - Intervention for the Treatment of Globus Pharyngeus
NCT06762444
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
NCT06866964
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
NCT07223749
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
NCT06958107
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
NCT07031739
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NCT06883097
Standardized Application of Feeding Evaluations Using SMART Tool
NCT07136610
Enhancing Physical Function in Older Adults With Chronic Kidney Disease
NCT06738394
The Better, Harder, Faster, Stronger Study
NCT07220512
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041
Nurturing Outreach for Understanding and Reducing Inpatient Security of Health
NCT07010289
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
NCT06945042
Identifying and Treating Depression in the Orthopaedic Trauma Population
NCT05976347
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets.Report a data error.